# Vertex Pharmaceuticals (VRTX) shares outstanding history

URL: https://funkfolio.com/stock/VRTX/shares-outstanding

> Vertex Pharmaceuticals (VRTX) shares outstanding were 258.00M in fiscal 2025, level with fiscal 2024. Over five fiscal years it shrank 0.4% a year.

---

## Vertex Pharmaceuticals (VRTX) shares outstanding

**Shares outstanding · fiscal 2025:** 258.00M year ended Dec 31, 2025

Vertex Pharmaceuticals (VRTX) had 258.00M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is level with fiscal 2024. Figures as of 18 Nov 2026, 11:33 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **Shares outstanding, fiscal 2025:** 258.00M
- **Change on fiscal 2024:** +0.0%
- **Growth, 5 years:** −0.4% a year
- **Growth, 10 years:** +0.7% a year
- **Highest on record:** 263.40M fiscal 2020
- **Lowest on record:** 140.56M fiscal 2008
- **Fiscal years on record:** 18 2008–2025

Figures as of 18 Nov 2026, 11:33 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

### Vertex Pharmaceuticals shares outstanding, in more detail

The market data feed counts 253.54M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count shrank at a compound 0.4% a year; over ten years the rate was 0.7% a year. Across the 18 fiscal years on record (2008–2025), the highest was 263.40M in fiscal 2020 and the lowest 140.56M in fiscal 2008.

### Shares outstanding by fiscal year

### Vertex Pharmaceuticals shares outstanding, year by year

Vertex Pharmaceuticals (VRTX) shares outstanding by fiscal year

| Fiscal year | Shares outstanding | Change | Year ended |
| --- | --- | --- | --- |
| 2025 | 258.00M | 0.0% up | Dec 31, 2025 |
| 2024 | 257.90M | 1.0% down | Dec 31, 2024 |
| 2023 | 260.50M | 0.5% up | Dec 31, 2023 |
| 2022 | 259.10M | 0.3% down | Dec 31, 2022 |
| 2021 | 259.90M | 1.3% down | Dec 31, 2021 |
| 2020 | 263.40M | 1.0% up | Dec 31, 2020 |
| 2019 | 260.70M | 0.6% up | Dec 31, 2019 |
| 2018 | 259.19M | 2.4% up | Dec 31, 2018 |
| 2017 | 253.23M | 3.5% up | Dec 31, 2017 |
| 2016 | 244.69M | 1.4% up | Dec 31, 2016 |
| 2015 | 241.31M | 2.6% up | Dec 31, 2015 |
| 2014 | 235.31M | 4.6% up | Dec 31, 2014 |
| 2013 | 224.91M | 4.5% up | Dec 31, 2013 |
| 2012 | 215.26M | 3.1% up | Dec 31, 2012 |
| 2011 | 208.81M | 4.2% up | Dec 31, 2011 |
| 2010 | 200.40M | 15.7% up | Dec 31, 2010 |
| 2009 | 173.26M | 23.3% up | Dec 31, 2009 |
| 2008 | 140.56M | — | Dec 31, 2008 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

### How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

### Shares outstanding at health care companies of similar size

Shares outstanding of Vertex Pharmaceuticals and comparable companies

| Company | Shares outstanding | Fiscal year |
| --- | --- | --- |
| [Pfizer PFE](https://funkfolio.com/stock/PFE/shares-outstanding) | 5.71B | 2025 |
| [Danaher DHR](https://funkfolio.com/stock/DHR/shares-outstanding) | 716.10M | 2025 |
| [Intuitive Surgical ISRG](https://funkfolio.com/stock/ISRG/shares-outstanding) | 362.70M | 2025 |
| Vertex Pharmaceuticals VRTX | 258.00M | 2025 |
| [Medtronic MDT](https://funkfolio.com/stock/MDT/shares-outstanding) | 1.29B | 2026 |
| [Bristol-Myers Squibb BMY](https://funkfolio.com/stock/BMY/shares-outstanding) | 2.04B | 2025 |

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

### Vertex Pharmaceuticals, figure by figure

- [Vertex Pharmaceuticals market cap](https://funkfolio.com/stock/VRTX/market-cap)
- [Vertex Pharmaceuticals revenue](https://funkfolio.com/stock/VRTX/revenue)
- [Vertex Pharmaceuticals earnings](https://funkfolio.com/stock/VRTX/earnings)
- [Vertex Pharmaceuticals earnings per share (EPS)](https://funkfolio.com/stock/VRTX/eps)
- [Vertex Pharmaceuticals P/E ratio](https://funkfolio.com/stock/VRTX/pe-ratio)
- [Vertex Pharmaceuticals P/S ratio](https://funkfolio.com/stock/VRTX/ps-ratio)
- [Vertex Pharmaceuticals P/B ratio](https://funkfolio.com/stock/VRTX/pb-ratio)
- [Vertex Pharmaceuticals free cash flow](https://funkfolio.com/stock/VRTX/free-cash-flow)
- [Vertex Pharmaceuticals operating margin](https://funkfolio.com/stock/VRTX/operating-margin)
- [Vertex Pharmaceuticals dividend](https://funkfolio.com/stock/VRTX/dividend)
- [Vertex Pharmaceuticals total debt](https://funkfolio.com/stock/VRTX/total-debt)
- [Vertex Pharmaceuticals cash on hand](https://funkfolio.com/stock/VRTX/cash)
- [Vertex Pharmaceuticals total assets](https://funkfolio.com/stock/VRTX/total-assets)
- [Vertex Pharmaceuticals return on equity (ROE)](https://funkfolio.com/stock/VRTX/roe)
- [Vertex Pharmaceuticals return on invested capital (ROIC)](https://funkfolio.com/stock/VRTX/roic)

[Vertex Pharmaceuticals (VRTX) overview: price, valuation and scorecard](https://funkfolio.com/stock/VRTX) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Vertex Pharmaceuticals shares outstanding: questions and answers

**How many shares does Vertex Pharmaceuticals have?**

Vertex Pharmaceuticals (VRTX) had 258.00M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is level with fiscal 2024. The market data feed counts 253.54M shares outstanding today.

**What is the growth rate of Vertex Pharmaceuticals's diluted share count?**

Over the five fiscal years to 2025 the diluted share count shrank at a compound 0.4% a year; over ten years the rate was 0.7% a year.

**What are the highest and lowest diluted share count figures on record for Vertex Pharmaceuticals?**

Across the 18 fiscal years on record (2008–2025), the highest was 263.40M in fiscal 2020 and the lowest 140.56M in fiscal 2008.

**How is Vertex Pharmaceuticals's diluted share count calculated?**

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Vertex Pharmaceuticals it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

### Learn: shares outstanding

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [What market capitalization is, and what it is not](https://funkfolio.com/learn/markets/market-capitalization)

  Market capitalization is the share price multiplied by the number of shares outstanding: 1 billion shares at $50 is a $50 billion company. It measures the size the stock market puts on a company's equity today. It is not a sale price, it ignores debt and cash, and index providers often count only the freely traded part, the float.
- [Market cap vs enterprise value: what is the difference?](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

  Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.

### Cite this page

Funkfolio, “Vertex Pharmaceuticals (VRTX) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/VRTX/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.
